Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3039744	s-rnapol3	— (—)	231	244	100.00%	Distribution not available
3039744	s-rnapoab	— (—)	103	107	100.00%	Distribution not available
3039744	s-rnapol3	u/ml (u/ml)	26	26	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Systemic connective tissue disorders

134

18.00

166.54

1.0

1.1

6.38

3.35

u/ml

—

Other systemic involvement of connective tissue

16.28

114.74

1.0

1.1

5.71

3.81

u/ml

—

ILD medications: immunosuppressive drugs

117

126

8.93

92.92

1.0

4.21

2.10

u/ml

—

ILD medications

161

146

6.06

70.90

1.0

1.1

6.90

2.15

u/ml

1.27

Finngen Rheumatological endpoints

143

120

6.81

70.71

1.0

1.1

5.50

2.00

u/ml

—

ILD medications: prednisolone, methylprednisolone, prednisone

149

144

5.86

64.63

1.1

6.90

2.15

u/ml

1.27

Reimbursement for rheumatic diseases

102

174

5.86

56.74

1.0

1.1

8.07

3.78

u/ml

—

Inflammatory bowel disease treatment related agents

152

184

4.70

53.32

1.0

1.1

6.32

2.09

u/ml

1.25

Oral corticosteroids

142

179

4.81

52.49

1.0

1.1

5.70

2.09

u/ml

0.86

Second line medication for Crohn's disease

173

5.33

46.33

1.0

1.1

4.75

5.28

u/ml

—

L04AX Other immunosuppressants

164

5.44

45.83

1.0

1.1

4.75

5.47

u/ml

—

Other specific joint derangements/joint disorders

103

126

5.49

45.74

1.0

1.1

5.75

2.10

u/ml

—

Pain in joint

6.21

44.14

1.0

1.1

3.00

4.75

u/ml

—

First line medication for Crohn's disease

133

163

4.46

43.32

1.0

1.1

7.11

2.09

u/ml

1.23

Polyarthropathies

113

5.26

37.82

1.0

1.1

6.03

2.10

u/ml

—

Autoimmune diseases excluding thyroid diseases

122

168

4.03

35.73

1.1

1.0

2.70

2.38

u/ml

—

Autoimmune diseases excluding thyroid diseases, strict definition

115

165

3.89

32.26

1.1

1.0

2.70

2.38

u/ml

—

Autoimmune diseases related-to ILD

230

3.71

30.03

1.0

1.1

5.93

3.47

u/ml

—

Abnormal findings on diagnostic imaging of lung

113

5.01

27.14

1.1

1.0

9.63

2.75

u/ml

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

163

4.10

25.97

1.1

1.0

9.78

2.40

u/ml

—

Autoimmune diseases

105

168

3.19

21.87

1.1

1.0

6.30

2.38

u/ml

—

Used for control exclusion in common control thyroid runs

157

3.07

18.64

1.1

1.0

5.67

2.36

u/ml

0.84

Renal failure

4.35

18.30

1.1

1.0

6.17

5.54

u/ml

—

Arthropathies

129

3.28

18.02

1.1

5.09

2.10

u/ml

—

Abnormalities of breathing

182

2.84

15.95

1.0

5.35

3.15

u/ml

—

Infections, IBD-co-morbidities

9.45

15.82

1.0

7.10

—

u/ml

—

Rheumatoid arthritis, including avohilmo

120

3.84

15.67

1.0

8.80

3.36

u/ml

—

Gastro-oesophageal reflux disease

189

3.05

15.08

1.0

3.00

4.91

u/ml

—

Other joint disorders

129

3.06

14.79

1.1

6.43

2.10

u/ml

—

Fever of other and unknown origin

148

3.32

14.33

1.0

2.30

2.63

u/ml

—

Systemic lupus erythematosus

34.40

13.52

1.1

1.2

—

Other bacterial diseases

214

2.62

13.44

1.1

1.0

7.04

2.87

u/ml

0.78

Dyspnoea

239

2.57

13.11

1.0

1.1

7.67

3.84

u/ml

—

Dermatitis and eczema

265

2.38

12.91

1.0

1.1

2.08

5.08

u/ml

—

SLE, ICD10

22.79

12.91

1.1

—

SLE, strict definition

22.79

12.91

1.1

—

Diseases of oesophagus, stomach and duodenum

238

2.40

12.66

1.1

1.0

5.11

4.21

u/ml

0.13

Bacterial infection, other or unspecified

120

3.39

12.48

1.1

1.0

8.20

3.61

u/ml

—

Renal tubulo-interstitial diseases

234

2.52

12.25

1.1

1.0

8.06

2.95

u/ml

—

Systemic lupus erythematosus, unspecified

30.38

11.66

1.1

1.2

—

Bacterial Sepsis

107

3.41

11.49

1.1

1.0

8.94

3.25

u/ml

—

Implicit bacterial Sepsis

3.54

11.04

1.1

1.0

9.69

3.50

u/ml

—

General symptoms and signs

193

2.29

10.18

1.1

1.0

7.31

2.64

u/ml

1.01

Hypothyroidism, strict autoimmune

142

2.66

9.75

1.0

12.25

2.45

u/ml

—

Symptoms and signs involving the digestive system and abdomen

175

2.32

9.70

1.1

1.0

5.06

5.03

u/ml

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

264

2.20

9.48

1.1

1.0

7.77

2.65

u/ml

0.94

Diseases of the skin and subcutaneous tissue

183

2.25

9.19

1.1

1.0

2.69

5.55

u/ml

—

Heart failure, not strict

156

2.52

8.92

1.1

1.0

10.44

2.58

u/ml

—

Pain (limb, back, neck, head abdominally)

2.71

8.66

1.1

4.25

4.59

u/ml

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

240

2.09

8.64

1.0

1.1

4.75

4.40

u/ml

—

Bacterial intestinal infections, IBD co-morbidities

4.38

8.60

1.0

1.1

7.00

3.81

u/ml

—

Pneumonia, organism unspecified

229

2.21

8.37

1.1

1.0

8.67

2.69

u/ml

—

Localized scleroderma [morphea]

+∞

8.35

1.1

0.0

—

Influenza and pneumonia

264

2.07

8.23

1.1

1.0

8.20

2.69

u/ml

—

Headache

183

2.42

8.05

1.1

1.0

6.57

2.56

u/ml

—

Abdominal and pelvic pain

175

2.18

8.04

1.1

1.0

3.08

5.03

u/ml

—

Other bacterial intestinal infections

4.13

7.98

1.0

7.00

3.81

u/ml

—

210

2.15

7.80

1.1

1.0

8.30

2.25

u/ml

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

210

2.15

7.80

1.1

1.0

8.30

2.25

u/ml

—

Soft tissue disorders

204

2.06

7.55

1.0

1.1

5.28

4.88

u/ml

—

Symptoms and signs involving the circulatory and respiratory systems

183

2.11

7.52

1.0

6.25

3.15

u/ml

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

260

2.00

6.90

1.1

1.0

8.20

2.69

u/ml

—

Any gastric operation

137

2.24

6.86

1.0

1.1

3.00

3.45

u/ml

—

GASTRO-related operations

137

2.24

6.86

1.0

1.1

3.00

3.45

u/ml

—

Asthma, excluding more controls

123

2.34

6.85

1.0

5.00

1.81

u/ml

—

Pneumonias (Asthma/COPD co-morbidities)

267

1.97

6.80

1.1

1.0

8.20

2.69

u/ml

—

All pneumoniae

267

1.97

6.73

1.1

1.0

8.20

2.69

u/ml

—

Implicit Sepsis

185

2.23

6.64

1.1

1.0

9.69

3.14

u/ml

—

Psoriatic and enteropathic arthropathies

5.73

6.58

1.1

—

Asthma

127

2.28

6.51

1.0

5.00

1.81

u/ml

—

Persons encountering health services in other circumstances, wide

240

1.88

6.37

1.0

1.1

4.67

4.40

u/ml

—

Complications of procedures, not elsewhere classified

263

2.04

6.37

1.1

1.0

6.00

4.30

u/ml

—

Haemolytic-uraemic syndrome

+∞

6.32

1.0

0.0

—

Other pulmonary diagnosis

129

2.21

6.31

1.0

6.50

2.72

u/ml

—

Condition for Implicit Sepsis (Organ dysfunction codes)

216

2.05

6.18

1.1

1.0

8.15

2.63

u/ml

—

Complications of surgical and medical care, not elsewhere classified

273

1.92

6.12

1.1

1.0

6.00

4.20

u/ml

—

Cough

111

2.68

6.04

1.0

6.67

3.67

u/ml

—

Episodal and paroxysmal disorders

228

1.84

5.68

1.0

8.14

2.37

u/ml

1.10

Symptoms and signs involving the skin and subcutaneous tissue

258

2.05

5.68

1.1

1.0

1.70

5.22

u/ml

—

Excluding asthma or asthma-COPD overlap

129

2.14

5.64

1.0

6.50

2.72

u/ml

—

COPD/asthma related infections

210

1.86

5.53

1.1

1.0

6.60

2.25

u/ml

—

COPD/asthma/ILD related infections

210

1.86

5.53

1.1

1.0

6.60

2.25

u/ml

—

Malaise and fatigue

115

2.47

5.47

1.1

1.0

6.90

2.71

u/ml

—

Diseases of the ear and mastoid process

251

1.77

5.41

1.1

2.61

5.58

u/ml

—

COPD differential diagnosis

130

2.08

5.23

1.0

7.56

1.81

u/ml

—

ILD differential diagnosis

130

2.08

5.23

1.0

7.56

1.81

u/ml

—

Nerve, nerve root and plexus disorders

264

1.79

4.99

1.1

1.0

2.93

5.09

u/ml

—

Gastrointestinal diseases

2.22

4.89

1.1

1.0

3.40

1.50

u/ml

—

Septicaemia

2.61

4.85

1.0

13.00

4.21

u/ml

—

Other heart diseases, wide

229

1.82

4.71

1.1

1.0

8.50

2.38

u/ml

—

Other and unspecified rosacea

4.41

4.56

1.1

—

3.40

—

Gout, idiopatic and unspecified

3.15

4.48

1.1

6.07

3.17

u/ml

—

Neurological diseases

168

1.86

4.47

1.1

1.0

2.50

2.72

u/ml

—

Disorders of the thyroid gland

247

1.77

4.44

1.1

9.81

2.53

u/ml

—

Other and unspecified iron deficiency

2.55

4.36

1.1

12.75

3.10

u/ml

—

Gout, FINNGEN

2.91

4.16

1.1

1.0

5.44

3.60

u/ml

—

Persons encountering health services for specific procedures and health care

272

1.69

4.10

1.1

7.07

3.73

u/ml

—

Tramadol

193

1.83

4.07

1.0

4.72

4.91

u/ml

—

Glomerular diseases

3.20

4.05

1.1

1.0

—

3.79

—

Hypothyroidism, other/unspecified

241

1.73

3.87

1.0

1.1

12.25

2.50

u/ml

—

Heart failure,strict

2.23

3.86

1.1

1.0

10.50

2.89

u/ml

—

Nutritional anaemias

148

2.10

3.80

1.1

1.0

9.17

2.73

u/ml

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

253

1.70

3.77

1.0

1.1

10.79

2.53

u/ml

—

Direct fill therapy

3.53

3.76

1.1

1.0

—

3.40

—

Explicit Sepsis

116

2.23

3.69

1.0

13.00

3.50

u/ml

—

Other heart diseases

121

2.02

3.67

1.1

1.0

9.50

3.50

u/ml

—

Other infective otitis externa

6.68

3.67

1.0

1.1

—

Cardiac arrhythmias

173

1.83

3.62

1.1

6.36

3.79

u/ml

—

Kidney transplant status

7.80

3.56

1.1

1.0

—

Certain infectious and parasitic diseases

196

1.69

3.55

1.1

1.0

10.06

2.54

u/ml

—

Iron deficiency anaemia

129

2.15

3.54

1.1

1.0

11.21

2.95

u/ml

—

Neurological diseases, wide definition

3.51

3.53

1.1

1.0

—

Acute tubulo-interstitial nephritis

177

1.90

3.42

1.1

1.0

7.90

3.30

u/ml

—

247

1.60

3.40

1.1

1.0

10.38

2.36

u/ml

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

273

1.64

3.38

1.1

2.09

6.08

u/ml

1.26

Hypertensive diseases

189

1.71

3.32

1.0

7.21

5.14

u/ml

—

Exposure to other specified factors

265

1.73

3.31

1.0

1.1

6.20

4.39

u/ml

—

Disorders of skin appendages

175

1.94

3.31

1.0

1.1

—

5.75

—

Other disorders of ear

235

1.67

3.31

1.1

1.0

2.86

5.61

u/ml

—

Chronic tubulo-interstitial nephritis

8.60

3.26

1.2

1.0

—

Rosacea

3.16

3.21

1.1

—

3.00

—

Gout, strict definition

3.34

3.19

1.0

1.1

6.60

3.00

u/ml

—

Sleep apnoea

237

1.66

3.19

1.0

11.17

3.13

u/ml

—

Codeine

215

1.64

3.18

1.0

2.58

4.91

u/ml

—

Other disorders of lacrimal gland

110

2.18

3.18

1.1

1.0

—

5.54

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

264

1.62

3.17

1.1

1.0

6.80

4.58

u/ml

—

Other arrhythmias

173

1.82

3.13

1.1

1.0

3.94

2.45

u/ml

—

Chronic gastritis

2.54

3.12

1.1

1.0

—

8.60

—

Acute upper respiratory infections

264

1.59

3.08

1.0

13.00

2.27

u/ml

—

Intestinal infectious diseases

283

1.62

3.06

1.1

1.0

6.33

4.26

u/ml

—

Deep endometriosis

3.45

3.04

1.0

1.1

—

4.75

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

248

1.62

3.00

1.0

1.1

12.25

2.58

u/ml

—

Polyarthritis, unspecified

10.03

2.98

1.0

—

Sleep apnoea, including avohilmo

246

1.61

2.97

1.0

1.1

9.71

3.02

u/ml

—

Dizziness and giddiness

219

1.71

2.91

1.1

1.75

6.21

u/ml

—

Heart failure, strict

115

1.94

2.87

1.1

1.0

9.56

3.70

u/ml

—

Reactive arthropathies, FINNGEN

5.39

2.87

1.1

1.2

—

Hypertension

189

1.65

2.86

1.0

7.21

5.14

u/ml

—

Other disorders of eye and adnexa

2.93

2.85

1.1

—

3.79

—

Disorders of lacrimal system

143

1.96

2.83

1.1

1.0

—

4.76

—

Psoriatic arthropathies

3.92

2.77

1.1

1.0

—

Sleep disorders (combined)

259

1.57

2.76

1.0

1.1

9.71

2.98

u/ml

—

All-cause Heart Failure

112

1.93

2.75

1.1

1.0

9.56

3.70

u/ml

—

Pericarditis

8.36

2.75

1.2

1.0

—

Crohn disease (strict definition, require KELA, min 2 HDR)

5.01

2.73

1.0

1.1

—

Crohn disease (strict definition, require KELA)

5.01

2.73

1.0

1.1

—

Spondylopathies

170

1.68

2.69

1.0

1.1

5.43

3.79

u/ml

—

Presence of cardiac and vascular implants and grafts

2.06

2.67

1.0

7.20

6.56

u/ml

—

Disorders of tooth development and eruption

5.85

2.64

1.2

1.0

—

Diseases of the respiratory system

102

1.82

2.63

1.1

4.08

1.83

u/ml

—

Alcohol-induced chronic pancreatitis

5.46

2.54

1.0

—

Non-ischemic cardiomyopathy

2.20

2.51

1.1

7.25

2.14

u/ml

—

Bacterial pneumonia (organism specified)

123

1.93

2.50

1.0

7.00

5.35

u/ml

—

Symptoms and signs involving the urinary system

206

1.65

2.50

1.1

1.0

3.81

5.84

u/ml

—

Disorders of vitreous body

154

1.84

2.49

1.1

1.0

1.83

7.46

u/ml

—

Benzodiazepine use

290

1.52

2.48

1.0

1.1

7.60

3.86

u/ml

—

Endometriosis of rectovaginal septum and vagina

3.82

2.46

1.0

—

Sequelae of external causes of morbidity and mortality

2.29

2.40

1.1

1.0

—

3.72

—

Asthma, including avohilmo

289

1.47

2.39

1.1

1.0

5.00

4.38

u/ml

—

Leiomyoma of uterus

160

1.64

2.39

1.0

1.1

6.17

3.88

u/ml

—

Disorders of vitreous body and globe

156

1.81

2.37

1.1

1.0

1.83

7.03

u/ml

—

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

6.27

2.37

1.0

1.1

—

Varicella [chickenpox]

6.26

2.37

1.0

1.1

—

Other diseases of lip and oral mucosa

2.61

2.35

1.0

—

3.79

—

Chronic lower respiratory diseases

279

1.45

2.32

1.0

1.1

6.67

3.55

u/ml

—

Bacterial pneumoniae

1.99

2.32

1.0

7.00

3.83

u/ml

—

Syncope and collapse

105

1.94

2.27

1.1

1.0

4.60

3.00

u/ml

—

Other Crohn's disease

4.29

2.15

1.0

1.1

—

Other predominantly sexually transmitted diseases, not elsewhere classified

2.30

2.14

1.1

1.0

—

3.50

—

Cervicalgia

2.30

2.14

1.0

—

5.25

—

Other diseases of intestines

263

1.46

2.13

1.0

1.1

8.56

2.73

u/ml

—

Codeine or tramadol medication

273

1.44

2.13

1.1

1.0

2.25

5.40

u/ml

—

Other disorders of teeth and supporting structures

2.21

2.10

1.1

1.0

—

6.85

—

Coagulation defects, purpura and other haemorrhagic conditions

2.45

2.10

1.0

1.1

—

3.79

—

Fracture of femur

2.28

2.08

1.1

1.90

6.06

u/ml

—

Other psoriatic arthropathies

2.91

2.07

1.1

—

3.40

—

Biological medication for rheuma

2.40

2.02

1.0

—

3.40

—

Other dorsopathies, not elsewhere classified

215

1.47

2.01

1.0

1.1

11.08

3.60

u/ml

—

Psoriatic arthropathies, ICD10

2.82

2.00

1.1

—

3.40

—

Arthropathic psoriasis

2.82

2.00

1.2

1.1

—

3.40

—

Vocal cord dysfunction

3.42

1.99

1.0

—

Bacterial pneumonia, not elsewhere classified

1.92

1.96

1.1

1.0

7.00

3.83

u/ml

—

Tobacco use

4.55

1.94

1.2

1.1

—

Migraine without aura

2.19

1.94

1.1

—

2.92

—

Missing teeth due to accident, extraction or parodontitis

2.73

1.93

1.1

1.0

—

3.92

—

Keratitis

113

1.86

1.91

1.0

—

8.17

—

Stroke, including SAH

143

1.66

1.89

1.1

1.0

1.50

7.17

u/ml

—

Cerebrovascular diseases

172

1.58

1.88

1.1

1.0

3.00

6.28

u/ml

—

Unspecified mental disorder

156

0.38

1.88

1.0

1.1

—

5.21

—

STROKE

140

1.64

1.85

1.1

1.0

1.50

5.28

u/ml

—

Tumor necrosis factor alpha inhibitors

2.39

1.85

1.0

—

3.40

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

3.53

1.83

1.0

1.1

—

Other and unspecified disorders of vitreous body

136

1.76

1.83

1.0

1.60

7.88

u/ml

—

Spinal stenosis

106

1.77

1.82

1.0

5.43

4.23

u/ml

—

Acute lymphadenitis

4.17

1.82

1.2

1.0

—

Paracetamol of NSAID medication

2.83

1.82

1.1

1.0

—

Crohn's disease of small intestine

4.17

1.82

1.0

1.1

—

Other disorders of urethra and urinary system

224

1.51

1.82

1.0

1.1

6.00

4.18

u/ml

—

Ulcer of lower limb, not elsewhere classified

3.05

1.79

1.1

—

3.58

—

Infections with a predominantly sexual mode of transmission

116

1.81

1.77

1.1

—

4.33

—

Kela-code for severe mental illness

135

0.37

1.74

1.0

—

5.92

—

Parasetamol

148

1.52

1.73

1.1

7.70

3.00

u/ml

—

Other blood glucose lowering drugs, excl. Insulins

0.00

1.69

0.0

1.0

—

3.50

—

Open wound of lower leg

2.38

1.67

1.2

1.0

—

2.79

—

Hypertension, essential

187

1.46

1.65

1.0

6.93

5.14

u/ml

—

Other complications of surgical and medical care, not elsewhere classified

2.80

1.65

1.0

1.1

—

4.50

—

Other noninfective gastroenteritis and colitis

2.03

1.64

1.1

1.0

—

3.72

—

Congenital malformations of eye, ear, face and neck

3.58

1.61

1.0

1.1

—

Benign neoplasm: Ascending colon

2.50

1.59

1.0

1.1

—

3.10

—

Covid-19 suspected case

2.00

1.59

1.1

1.0

—

3.08

—

Dorsopathies

215

1.40

1.58

1.0

1.1

8.69

3.60

u/ml

—

Inflammatory disease of uterus

2.20

1.56

1.1

—

4.60

—

Exclusions for E4_PCOS_CONSORTIUM

204

1.44

1.55

1.0

1.1

7.50

3.39

u/ml

—

Bronchitis

291

1.37

1.54

1.1

1.0

8.43

3.25

u/ml

—

Shoulder lesions

169

1.49

1.54

1.0

1.1

1.60

5.13

u/ml

—

Stroke, excluding SAH

135

1.60

1.54

1.1

1.0

1.50

7.17

u/ml

—

Abnormal findings on diagnostic imaging of other body structures

2.43

1.53

1.0

—

3.00

—

Pollen allergy

2.01

1.50

1.1

—

3.50

—

Other symptoms and signs involving cognitive functions and awareness

123

1.68

1.47

1.0

2.50

9.45

u/ml

—

Opioids

216

1.39

1.46

1.1

1.0

6.36

4.91

u/ml

—

Crohn disease

2.37

1.45

1.0

1.1

—

3.40

—

Constipation

232

1.42

1.44

1.0

7.10

4.58

u/ml

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

3.13

1.44

1.2

1.1

—

3.10

—

Recurrent dislocation and subluxation of joint

3.13

1.44

1.0

1.1

—

Injuries to the hip and thigh

135

1.63

1.43

1.1

1.90

7.46

u/ml

—

Fitting and adjustment of other devices

1.80

1.43

1.0

1.1

3.00

5.68

u/ml

—

Dental pulpitis 1

246

1.35

1.42

1.1

1.0

2.10

5.48

u/ml

—

Diseases of pulp and periapical tissues, including avohilmo

246

1.35

1.42

1.1

1.0

2.10

5.48

u/ml

—

Dental pulpitis 4

246

1.35

1.42

1.1

1.0

2.10

5.48

u/ml

—

Chronic sinusitis

150

1.60

1.37

1.0

1.1

—

6.63

—

Ulcerative colitis, NAS

2.20

1.36

1.0

—

3.40

—

Benign neoplasm: Ascending colon

2.36

1.29

1.0

1.1

—

2.50

—

Other embolism and thrombosis

2.35

1.29

1.0

1.1

—

4.06

—

Metabolic disorders

237

1.36

1.29

1.1

1.0

7.70

4.29

u/ml

—

Viral hepatitis

2.78

1.28

1.2

1.0

—

Bleeding

205

1.42

1.28

1.1

1.0

8.06

3.29

u/ml

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

114

1.67

1.27

1.1

1.0

—

5.57

—

Diabetic nephropathy, excluding more controls

2.30

1.27

1.3

1.1

—

6.83

—

Use of hypnotics and sedatives

261

1.33

1.26

1.0

1.1

2.88

5.38

u/ml

—

Diabetic nephropathy

2.26

1.25

1.3

1.1

—

2.14

—

Diseases of the eye and adnexa

178

1.38

1.25

1.1

1.0

3.40

4.80

u/ml

—

Superficial injury of lower leg

1.82

1.25

1.0

—

6.50

—

Benign neoplasm: Caecum

2.40

1.24

1.2

1.0

—

2.75

—

Benign neoplasm: Caecum

2.40

1.24

1.2

1.0

—

3.10

—

Zoster [herpes zoster]

2.00

1.23

1.0

1.1

—

2.94

—

Other sexually transmitted chlamydial diseases

2.63

1.21

1.2

1.1

—

Diseases of pulp and periapical tissues

124

1.61

1.20

1.0

—

5.73

—

Other inflammation of eyelid

2.11

1.18

1.1

—

3.92

—

Sequelae with surgical and medical care as external cause

1.93

1.16

1.1

—

3.72

—

Car occupant injured in other and unspecified transport accidents

1.93

1.16

1.1

—

4.25

—

Benign neoplasm of meninges

0.00

1.16

0.0

1.0

—

2.75

—

Benign neoplasm of other and unspecified endocrine glands

2.05

1.15

1.0

1.1

—

3.79

—

Hard cardiovascular diseases

174

1.40

1.14

1.1

1.0

6.00

4.97

u/ml

—

Endocrine, nutritional and metabolic diseases

185

1.35

1.12

1.1

1.0

3.50

3.00

u/ml

—

Benign neoplasm of other and unspecified endocrine glands

2.00

1.12

1.0

1.1

—

3.79

—

Schizophrenia or delusion

114

0.44

1.12

1.0

—

6.18

—

Schizophrenia, schizotypal and delusional disorders

115

0.43

1.11

1.0

—

6.18

—

Heart failure and bmi 25plus

1.70

1.10

1.1

1.0

9.30

3.43

u/ml

—

Chronic rhinitis, nasopharyngitis and pharyngitis

104

1.64

1.09

1.0

—

7.83

—

Myocardial infarction, with ST-elevation

2.19

1.08

1.0

—

2.67

—

Myocardial infarction, without ST-elevation

1.63

1.07

1.1

—

5.66

—

Disorders of gallbladder, biliary tract and pancreas

267

1.30

1.05

1.0

1.1

8.20

3.89

u/ml

—

Other intervertebral disc disorders

195

1.35

1.04

1.0

1.1

8.50

3.60

u/ml

—

Acute upper respiratory infections of multiple and unspecified sites

221

1.36

1.03

1.1

1.0

10.80

2.36

u/ml

—

Dental pulpitis 4, only avohilmo

253

1.28

1.02

1.1

1.0

2.10

5.48

u/ml

—

Erosion of teeth, including avohilmo

1.83

1.02

1.1

—

3.92

—

Sensorineural hearing loss

177

1.38

1.01

1.1

1.0

3.00

6.25

u/ml

—

Malignant neoplasm of digestive organs

108

0.46

1.00

1.0

—

6.50

—

Acute laryngitis and tracheitis

1.97

0.98

1.0

—

Benign neoplasm: Cerebral meninges

0.00

0.97

0.0

1.0

—

2.75

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

0.00

0.96

0.0

1.1

—

3.50

—

Chondropathies

1.77

0.94

1.1

—

3.79

—

Chronic periodontitis, including avohilmo

261

1.30

0.94

1.1

1.0

1.92

5.26

u/ml

—

Chronic periapical parodontitis

1.72

0.92

1.0

—

7.28

—

Long labour

102

1.54

0.92

1.1

1.0

—

3.10

—

Parodontitis

261

1.30

0.92

1.1

1.0

1.92

5.41

u/ml

—

Parodontitis or operation codes

262

1.29

0.89

1.1

1.0

1.92

5.41

u/ml

—

Medical treatment for female infertility

1.59

0.89

1.0

1.1

—

2.90

—

Schizophrenia or delusion, excluding more controls

104

0.48

0.88

1.0

—

5.83

—

Retinal detachments and breaks

111

1.53

0.87

1.1

1.0

—

7.10

—

Dental pulpitis 1, only avohilmo

255

1.25

0.86

1.1

1.0

2.10

5.48

u/ml

—

Nonsuppurative otitis media

1.67

0.84

1.0

1.1

—

3.93

—

D07AA Corticosteroids, weak (group I)

1.78

0.84

1.0

—

3.40

—

Thyrotoxicosis, other and/or unspecified

1.76

0.83

1.2

1.0

—

3.06

—

Fracture of skull and facial bones

1.69

0.82

1.0

1.1

—

7.50

—

Pregnancy with abortive outcome

156

1.31

0.79

1.1

8.40

3.33

u/ml

—

Biguanides

253

0.75

0.79

1.1

1.0

2.60

5.34

u/ml

—

Use of rivastigmine

0.00

0.79

0.0

1.1

—

3.42

—

Pruritus

1.82

0.79

1.2

1.1

—

4.90

—

Benign neoplasm: Cerebral meninges

0.00

0.78

0.0

1.1

—

2.75

—

Non-small cell lung cancer

1.77

0.76

1.2

1.1

—

3.58

—

Benign neoplasm of bone and articular cartilage

0.00

0.76

0.0

1.1

—

4.25

—

Benign neoplasm of meninges

0.00

0.76

0.0

1.1

—

2.75

—

Migraine without aura and triptan purchases

1.70

0.75

1.2

1.1

—

1.50

—

Other disorders of bone

1.70

0.75

1.1

—

3.79

—

Corneal ulcer

1.67

0.74

1.1

—

4.25

—

Fall on same level

285

1.22

0.73

1.0

1.1

5.07

4.52

u/ml

—

Ptosis of eyelid

2.00

0.72

1.0

1.1

—

2.70

—

Psoriasis vulgaris

1.61

0.72

1.1

—

3.79

—

Nontoxic multinodular goitre

1.61

0.72

1.0

1.1

—

2.89

—

Thyrotoxicosis

1.55

0.71

1.2

1.0

—

6.45

—

Degenerative macular diseases

1.92

0.70

1.0

1.1

—

3.50

—

Other medical care

115

1.44

0.69

1.1

—

5.04

—

Selective serotonin reuptake inhibitors

232

1.23

0.69

1.0

6.44

4.00

u/ml

—

Retinal vascular occlusion

1.85

0.68

1.0

1.1

—

3.50

—

Lyme disease

1.56

0.68

1.1

1.0

—

6.95

—

Complications predominantly related to the puerperium

110

1.46

0.68

1.2

1.0

—

3.82

—

Rash and other nonspecific skin eruption

1.79

0.66

1.4

1.1

—

4.90

—

Retinal vascular disorders

1.79

0.66

1.0

1.1

—

3.50

—

Other spirochaetal diseases

1.54

0.65

1.1

1.0

—

6.95

—

Other external causes of accidental injury

177

1.25

0.65

1.1

3.40

3.36

u/ml

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1.58

0.64

1.0

—

3.40

—

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

108

0.65

0.61

1.0

—

3.39

—

Melanocytic naevi, other sites/unspecified

0.00

0.60

0.0

1.1

—

4.90

—

Benign neoplasm of bone and articular cartilage

0.00

0.60

0.0

1.1

—

DVT of lower extremities

1.54

0.59

1.0

—

4.06

—

Premature rupture of membranes

1.43

0.58

1.3

1.0

—

2.90

—

Skin changes due to chronic exposure to nonionizing radiation

100

1.42

0.57

1.1

1.0

—

5.04

—

Antepartum haemorrhage, not elsewhere classified

1.72

0.57

1.0

1.1

—

2.90

—

Benign neoplasms

227

1.21

0.57

1.0

1.1

2.10

4.14

u/ml

—

Noninfectious colitis NAS

1.67

0.56

1.0

1.1

—

3.69

—

Use of pramipexole

1.54

0.55

1.0

—

3.72

—

Parodontitis and operation codes

262

1.22

0.55

1.1

1.0

2.10

5.22

u/ml

—

Fracture of rib(s), sternum and thoracic spine

1.46

0.54

1.0

1.1

—

3.63

—

Unspecified lump in breast

1.48

0.53

1.0

—

7.15

—

Falls/tendency to fall

251

1.18

0.53

1.1

6.00

4.53

u/ml

—

Viral and other specified intestinal infections

1.47

0.53

1.0

1.1

—

3.40

—

Artrosis, including avohilmo

190

1.21

0.53

1.0

1.1

2.40

5.09

u/ml

—

Voice disturbances

1.45

0.51

1.0

—

7.00

—

Nontoxic goitre/thyroid nodule

100

1.40

0.51

1.1

1.0

—

5.54

—

Other metabolic disorders

1.50

0.51

1.0

1.1

—

3.50

—

Hypo-osmolality and hyponatraemia

1.50

0.51

1.2

1.1

—

5.50

—

Other extrapyramidal and movement disorders in other diseases

1.41

0.51

1.0

1.1

—

3.72

—

Endometriosis ASRM stages 1,2

1.47

0.50

1.1

—

4.75

—

Exclusions for E4_PCOS_BROAD

1.55

0.48

1.1

—

4.25

—

Hernia

257

1.19

0.48

1.1

1.0

3.42

5.53

u/ml

—

L02BG Aromatase inhibitors

108

0.65

0.48

1.0

—

5.88

—

Triptan medication for migraine, single purchase ok

239

1.19

0.47

1.1

1.0

7.92

4.33

u/ml

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

239

1.19

0.47

1.1

1.0

7.92

4.33

u/ml

—

Actinic keratosis

1.37

0.46

1.1

—

5.04

—

Colorectal cancer, excluding all cancers (controls excluding all cancers)

0.60

0.45

1.0

—

3.54

—

Sequelae of injuries, of poisoning and of other consequences of external causes

1.45

0.44

1.0

—

6.44

—

Postpartum hemorraghe, parous women as controls

1.35

0.42

1.1

—

4.50

—

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

0.65

0.42

1.0

—

4.15

—

Benign neoplasm of mouth and pharynx

1.56

0.42

1.2

1.1

—

2.75

—

Other diseases of urinary system

253

1.16

0.42

1.0

1.1

6.56

4.00

u/ml

—

Benign neoplasm of mouth and pharynx

1.52

0.41

1.2

1.1

—

2.75

—

Bitten or struck by other mammals

1.52

0.41

1.0

1.1

—

3.40

—

Nonorganic sleeping disorders, excluding more controls

1.33

0.40

1.1

1.0

—

4.17

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

1.43

0.39

1.0

1.1

—

4.70

—

Bacterial, viral and other infectious agents

0.00

0.39

0.0

1.1

—

Myocardial infarction

114

1.26

0.39

1.1

1.0

—

5.09

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

1.39

0.38

1.0

1.1

—

3.50

—

FESS (DNB20)

1.39

0.38

1.0

1.1

—

3.40

—

Unstable angina pectoris

0.71

0.37

1.0

1.1

—

4.50

—

Bipolar affective disorders

1.30

0.37

1.0

—

2.92

—

Malignant neoplasm of breast, HER-negative

0.66

0.35

1.0

—

6.59

—

Combinations of oral blood glucose lowering drugs

0.64

0.35

1.0

1.1

—

6.94

—

Thyrotoxicosis with diffuse goitre

1.43

0.35

1.2

1.0

—

1.58

—

Pain in thoracic spine

1.43

0.35

1.0

—

6.00

—

Benign neoplasm: Rectum

1.36

0.34

1.2

1.0

—

2.93

—

Postpartum hemorraghe, all women as controls

108

1.29

0.34

1.1

—

2.75

—

Other or unspecified ileus, impaction or obstruction

1.33

0.33

1.0

1.1

—

3.92

—

Varicose veins

184

0.82

0.33

1.0

9.50

4.12

u/ml

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

263

1.14

0.33

1.0

8.08

3.95

u/ml

—

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

1.32

0.33

1.2

1.0

—

2.50

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1.30

0.33

1.1

—

2.50

—

Gingivitis and periodontal diseases

189

1.15

0.32

1.1

1.0

2.30

4.47

u/ml

—

Benign neoplasm of other and ill-defined parts of digestive system

1.32

0.30

1.0

1.1

—

3.81

—

Other (not insulin) diabetes medications

255

0.87

0.30

1.1

1.0

2.33

5.34

u/ml

—

Puerperal sepsis

1.25

0.29

1.0

1.1

—

5.21

—

Benign neoplasm of other and ill-defined parts of digestive system

1.23

0.29

1.0

—

3.44

—

Injuries to the head

310

1.11

0.29

1.1

1.33

5.27

u/ml

—

Nonorganic sleeping disorders

1.29

0.28

1.1

1.0

—

3.40

—

Peritonsillar abscess

1.25

0.27

1.1

—

6.75

—

Other strabismus

0.70

0.26

1.0

1.1

—

3.79

—

Carbimazole or st.post thyroidectomy, condition for graves disease

1.25

0.25

1.2

1.0

—

3.50

—

Striking against or struck by other objects

105

1.24

0.24

1.2

1.0

—

5.50

—

Benign paroxysmal vertigo

1.26

0.24

1.0

—

5.81

—

Transport accidents

143

1.18

0.23

1.1

1.0

—

3.50

—

Restless leg syndrome

1.32

0.23

1.0

1.1

—

3.79

—

Ethmoidectomy

1.28

0.23

1.0

1.1

—

3.40

—

Recurring oral aphthae, including avohilmo

1.25

0.22

1.2

1.1

—

3.81

—

Algoneurodystrophy

0.00

0.21

0.0

1.1

—

Other inflammation of vagina/vulva

0.00

0.21

0.0

1.1

—

Use of biperiden

0.00

0.21

0.0

1.1

—

Maltreatment syndromes

0.00

0.21

0.0

1.1

—

Emotional disorders starting during childhood or adolescence

0.00

0.21

0.0

1.1

—

Other specified/unspecified inflammatory spondylopathies

0.00

0.21

0.0

1.1

—

Conjunctivitis (acute, non atopic)

1.23

0.20

1.0

—

3.65

—

Other disorders of breast

1.25

0.20

1.0

1.1

—

4.25

—

Dental operations

142

1.12

0.20

1.1

1.0

3.93

6.42

u/ml

—

Contact with and exposure to communicable diseases

122

0.82

0.19

1.0

1.1

—

2.50

—

LSIL lesion of the cervix uteri, vagina or vulva

1.18

0.19

1.0

1.1

—

3.50

—

Benign neoplasm: Rectum

1.18

0.19

1.2

1.0

—

3.44

—

Diabetes medication

285

0.92

0.19

1.1

1.0

2.33

5.34

u/ml

—

Abrasion of teeth

1.23

0.18

1.2

1.0

—

4.07

—

Postpartum haemorrhage

103

1.18

0.18

1.1

1.0

—

3.10

—

Other antidepressants

231

1.08

0.17

1.0

7.50

4.00

u/ml

—

Dental pulpitis 2

143

1.11

0.17

1.1

1.0

2.00

6.33

u/ml

—

Obstructed labour due to maternal pelvic abnormality

0.76

0.17

1.0

—

3.63

—

Other and unspecified nonorganic psychotic disorders

0.75

0.17

1.0

—

3.40

—

Procreative management

101

1.17

0.16

1.1

—

3.86

—

Effects of foreign body entering through natural orifice

1.14

0.16

1.0

—

7.21

—

Maternal care for known or suspected fetal abnormality and damage

1.11

0.16

1.3

1.0

—

2.90

—

Hypertrophy of breast in women and men

0.78

0.15

1.0

1.1

—

4.33

—

Malignant neoplasm of prostate

0.79

0.15

1.0

1.1

—

5.71

—

Diseases of male genital organs

1.13

0.11

1.0

1.1

—

5.83

—

Preterm labour and delivery

115

0.87

0.10

1.1

1.0

—

3.05

—

False labour

0.89

0.10

1.1

1.0

—

2.90

—

Other skin changes

1.14

0.10

1.0

1.1

—

4.06

—

Type 2 diabetes, definitions combined

249

1.05

0.09

1.0

6.00

4.26

u/ml

—

Maternal care for known or suspected abnormality of pelvic organs

0.88

0.09

1.2

1.0

—

2.75

—

Dislocation, sprain and strain of joints and ligaments at neck level

1.04

0.09

1.2

1.0

—

3.40

—

Insomnia

1.04

0.09

1.0

—

3.40

—

Type 2 diabetes, definitions combined, including avohilmo

253

1.05

0.09

1.0

6.00

4.26

u/ml

—

Dislocation, sprain and strain of joints and ligaments of knee

225

1.07

0.09

1.0

—

5.12

—

Depression or dysthymia

157

1.07

0.09

1.1

7.40

4.50

u/ml

—

Benign neoplasm: Rectum, anus and anal canal

1.05

0.08

1.2

1.0

—

3.31

—

Type 2 diabetes, strict (exclude DM1)

250

1.05

0.08

1.0

6.00

4.26

u/ml

—

Other disorders of amniotic fluid and membranes

1.04

0.08

1.2

1.1

—

2.90

—

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

1.02

0.08

1.2

1.0

—

2.50

—

Superficial injury of head

1.09

0.08

1.0

—

4.50

—

Injuries to the shoulder and upper arm

262

1.06

0.07

1.0

3.60

4.66

u/ml

—

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

0.85

0.07

1.2

1.1

—

2.56

—

Type 1 diabetes, wide definition

0.83

0.07

1.3

1.1

—

7.50

—

Paralytic ileus and intestinal obstruction

0.81

0.07

1.0

1.1

—

4.17

—

Hyperplasia of prostate

1.09

0.07

1.0

1.1

—

5.83

—

Intestinal stricture

1.12

0.06

1.0

1.1

—

7.46

—

Other diseases of the digestive system

1.12

0.06

1.0

1.1

—

5.46

—

Sub-endpoint used in defining T1D endpoints

0.88

0.06

1.3

1.0

—

5.86

—

Dental pulpitis 2, only avohilmo

146

1.05

0.05

1.1

1.0

2.00

6.33

u/ml

—

Myocardial infarction, strict

109

1.07

0.04

1.1

1.0

—

4.70

—

Disorders of vestibular function (Vertigo)

160

1.06

0.03

1.0

1.1

—

6.00

—

Persons with potential health hazards related to communicable diseases

146

0.95

0.02

1.0

1.1

—

2.91

—

Insulin, fast-acting

113

1.06

0.01

1.2

1.1

—

5.21

—

Type 2 diabetes

266

0.98

0.01

1.1

1.0

6.00

4.26

u/ml

—

Obstructed labour due to malposition and malpresentation of fetus

1.05

0.00

1.1

1.0

—

2.75

—

Diabetes, varying definitions

279

1.01

0.00

1.1

1.0

6.00

4.26

u/ml

—

Insulin, fast-acting or short human

118

1.02

0.00

1.2

1.1

—

5.00

—

Diabetes mellitus

281

1.00

0.00

1.1

1.0

6.00

4.26

u/ml

—

Extrapyramidal and movement disorders

110

1.00

0.00

1.0

1.1

—

5.82

—

Dental operations, only avohilmo

152

1.01

0.00

1.1

1.0

3.94

6.04

u/ml

—

Paranoid personality disorder

0.00

0.0

1.2

—

Background retinopathy and retinal vascular changes

0.00

0.0

1.0

—

Congenital malformations of breast

0.00

0.0

1.2

—

Seborrhoeic keratosis

0.88

0.00

1.0

1.1

—

6.15

—

Gonococcal infection

0.00

0.0

1.0

—

Total colectomy

0.00

0.0

1.1

—

Type 1 diabetes

0.88

0.00

1.3

1.1

—

7.50

—

Lesion of radial nerve

0.00

0.0

1.0

—

Viral agents as the cause of diseases classified to other chapters

0.00

0.0

1.0

—

Other salmonella infections

0.00

0.0

1.0

—

Other and unspecified epidermal thickening

0.00

0.0

1.2

—

Malignant neoplasm of brain

0.00

0.0

1.0

—

GI-bleeding

0.99

0.00

1.0

1.1

—

5.12

—

Poisoning by medicine

0.95

0.00

1.0

—

3.00

—

Scissor bite

0.00

0.0

1.2

—

Injury of muscle and tendon at ankle and foot level

0.00

0.0

1.1

—

Injury of nerves at wrist and hand level

0.00

0.0

1.1

—

Total colectomy operation

0.00

0.0

1.1

—

Major anomalies of jaw size

0.00

0.0

1.2

—

Sixth [abducent] nerve palsy

0.00

0.0

1.0

—

Superficial injuries involving multiple body regions

0.00

0.0

1.0

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1.00

0.00

1.0

—

7.94

—

Secondary parkinsonism+Parkinsonism in other disease

0.00

0.0

1.0

—

Burn and corrosion of head and neck

0.00

0.0

1.2

—

Hodgkin lymphoma, hilmo

0.00

0.0

1.1

—

Burn and corrosion confined to eye and adnexa

0.00

0.0

1.2

—

Blood alcohol or alcohol intoxication level

0.00

0.0

1.2

—

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

0.00

0.0

1.2

—

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Acute nephritic syndrome

0.00

0.0

1.0

—

Use of cabergoline

0.00

0.0

1.2

—

Habitual aborter

0.00

0.0

1.2

—

Correction of physiology of bite - very demanding therapy visit

0.00

0.0

1.1

—

Exclusion endpoint for clefts

0.00

0.0

1.0

—

Erythema intertrigo

0.00

0.0

1.2

—

Wide developmental disorders

0.00

0.0

1.2

—

Keratoconus

0.00

0.0

1.2

—

Other congenital malformations of circulatory system

0.00

0.0

1.0

—

Benign neoplasm: Long bones of lower limb

0.00

0.0

1.1

—

Somnolence, stupor and coma

0.00

0.0

1.2

—

Distal bite

0.00

0.0

1.1

—

Postprocedural disorders of digestive system, not elsewhere classified

0.00

0.0

1.1

—

Symptoms and signs involving emotional state

0.00

0.0

1.2

—

Other disorders of binocular movement

0.00

0.0

1.1

—

Cysts of oral region, not elsewhere classified

0.00

0.0

1.0

—

Meralgia paraesthetica

0.00

0.0

1.0

—

Melanocytic naevi of upper limb, including shoulder

0.00

0.0

1.1

—

Intussusception

0.00

0.0

1.2

—

Bulimia nervosa (incl. atypical)

0.00

0.0

1.0

—

Deep bite that required surgery

0.00

0.0

1.2

—

Other disorders of breast and lactation associated with childbirth

0.00

0.0

1.1

—

Anaemia in chronic diseases classified elsewhere

0.00

0.0

1.0

—

Suppurative otitis media, unspecified

0.00

0.0

1.2

—

Other and unspecified intracranial injuries

0.00

0.0

1.0

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

0.00

0.0

1.1

—

Open wound of abdomen, lower back and pelvis

0.00

0.0

1.2

—

Graves ophthalmopathy

0.00

0.0

1.0

—

Other and specified injuries of hip and thigh

0.00

0.0

1.2

—

Open wound of hip and thigh

0.00

0.0

1.2

—

Other assisted single delivery

0.00

0.0

1.2

—

Type 1 diabetes, wide definition, subgroup 1

0.87

0.00

1.3

1.1

—

7.50

—

Strabismus

0.95

0.00

1.1

1.0

—

3.56

—

Iridocyclitis in diseases classified elsewhere

0.00

0.0

1.2

—

Chorioretinal inflammation

0.00

0.0

1.0

—

Bacterial meningitis

0.00

0.0

1.1

—

Amblyopia ex anopsia

0.00

0.0

1.1

—

Disorders of lacrimal system and orbit in diseases classified elsewhere

0.00

0.0

1.0

—

0.00

0.0

1.1

—

Cerebral palsy

0.00

0.0

1.2

—

Disorders of orbit

0.00

0.0

1.1

—

Maternal care for known or suspected malpresentation of fetus

0.99

0.00

1.1

1.0

—

2.90

—

Schizotypal disorder

0.00

0.0

1.2

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

0.00

0.0

1.2

—

Mental and behavioural disorders due to cannabinoids

0.00

0.0

1.1

—

Endocrine disorders, other/unspecified

0.00

0.0

1.1

—

Burns and corrosions confined to eye and internal organs

0.00

0.0

1.2

—

Other and unspecified disorders of white blood cells

0.00

0.0

1.1

—

Benign neoplasm: Short bones of upper limb

0.00

0.0

1.0

—

Toxic effect of alcohol

0.00

0.0

1.2

—

Assault by unspecified means

0.00

0.0

1.2

—

Other facial nerve disorders

0.00

0.0

1.0

—

Evidence of alcohol involvement determined by blood alcohol level

0.00

0.0

1.2

—

Exposure to other and unspecified animate mechanical forces

0.00

0.0

1.2

—

Intentional self-harm by sharp object

0.00

0.0

1.2

—

Emphysema

0.00

0.0

1.0

—

0.00

0.0

1.2

—

Carrier of infectious disease

0.00

0.0

1.1

—

Benign neoplasm: Kidney

0.00

0.0

1.0

—

Superficial injury of neck

0.00

0.0

1.2

—

Benign neoplasm: Brain, supratentorial

0.00

0.0

1.2

—

Benign neoplasm: Anus and anal canal

0.00

0.0

1.0

—

malignant neoplasm of male genital organs

1.00

0.00

1.0

1.1

—

5.71

—

Malignant neoplasm of eye, brain and central nervous system

0.00

0.0

1.0

—

Personal history of certain other diseases

0.00

0.0

1.0

—

0.00

0.0

1.0

—

Benign neoplasm: Long bones of lower limb

0.00

0.0

1.1

—

Effects of other external causes

0.00

0.0

1.1

—

Benign neoplasm: Brain, supratentorial

0.00

0.0

1.2

—

Other disorders of iris and ciliary body

0.00

0.0

1.2

—

Other epidermal thickening

0.00

0.0

1.1

—

Specific development disorders of scholastic skills

0.00

0.0

1.1

—

Benign neoplasm: Rectum, anus and anal canal

1.02

0.00

1.2

1.1

—

3.28

—

Wide developmental disorders, excluding more controls

0.00

0.0

1.0

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

0.00

0.0

1.1

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

0.00

0.0

1.2

—

Syphilis

0.00

0.0

1.0

—

Other diseases of gallbladder

0.00

0.0

1.1

—

Oral leukoplakia, including avohilmo

0.00

0.0

1.0

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

RNA polymerase III Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS